![]() |
ACS News Center | |||||
|
|
||||||
|
||||||
| Breast Cancer Treatment Guidelines | |
| NCCN and ACS Provide Easy-to-Understand Information on Breast Cancer Treatment Options | |
| Article date: 1999/10/08 |
The National Comprehensive Cancer Network
(NCCN) and the American Cancer Society (ACS) teamed up to provide patients
and the general public the most current information about treatment options
for breast cancer patients. The ACS has translated the NCCN breast cancer
treatment guidelines, originally developed for oncologists? use, into an
understandable language and format for patients. The new guidelines became
available on March 1, 1999.
"The NCCN Oncology Practice Guidelines, which now cover more than 95 percent of all cancer patients, have become the treatment standard for oncology professionals," said William T. McGivney, PhD, Chief Executive Officer of NCCN, a nationwide network of 17 cancer centers. "We are proud our collaboration with the ACS will bring these guidelines to the patients who need them most." How the Guidelines Work The guidelines are helping people better understand breast cancer and their doctor?s advice. The treatment options for different stages of cancer are presented as flow charts. For each stage, the chart shows step-by-step how the patient and doctor can arrive at choices about treatment. Categories used in the flow charts are: cancer stage (stages indicate how far breast cancer has spread within the breast, to nearby tissues, and to other organs); work-up (the tests done to help determine the initial breast cancer diagnosis); treatment; prevention (what can be done to prevent a recurrence of the disease); and follow-up. For example, the stage for ductal carcinoma in situ (DCIS) is stage 0. The work-up is mammography of both breasts and biopsy and pathological review of the biopsy sample. The treatment options vary depending on the findings of the pathological review, but could include either a mastectomy with or without reconstruction or a lumpectomy with or without radiation. Prevention of a second cancer is an option, with a regimen of the drug tamoxifen for five years. Follow-up includes medical history and physical exam twice a year for five years, then once a year, along with a yearly mammogram. "Patients want detailed information about their treatment, so they can work with their doctor to formulate a treatment plan that best fits their needs, both medically and personally," said Ted Gansler, MD, MBA, director of health content for the ACS. "For more than 85 years, the public has relied on the American Cancer Society for accurate, up-to-date information about cancer and its treatment," said Charles J. McDonald, MD, president of the ACS. "This joint effort with the NCCN ensures that breast cancer patients will have the information they need to better understand the disease and act, in conjunction with their physician, to get treatment that is right for them." ACS News Center stories are provided as a source of cancer-related news and are not intended to be used as press releases. |